These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 15821633

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. ACOG Committee Opinion number 314, September 2005. Meningococcal vaccination for adolescents.
    American College of Obstetricians and Gynecologists.
    Obstet Gynecol; 2005 Sep; 106(3):667-9. PubMed ID: 16135612
    [Abstract] [Full Text] [Related]

  • 45. Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children.
    Granoff DM, Morgan A, Welsch JA.
    Vaccine; 2005 Jul 29; 23(34):4307-14. PubMed ID: 15921829
    [Abstract] [Full Text] [Related]

  • 46. Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Oct 10; 57(40):1100-3. PubMed ID: 18846032
    [Abstract] [Full Text] [Related]

  • 47. ACIP recommends meningococcal vaccine for adolescents and college freshmen.
    Mich Med; 2005 Oct 10; 104(4):22. PubMed ID: 16053236
    [No Abstract] [Full Text] [Related]

  • 48. An Advisory Committee Statement (ACS). Statement on recommended use of meningococcal vaccines.
    National Advisory Committee on Immunisation (NACI).
    Can Commun Dis Rep; 2001 Oct 15; 27():2-36. PubMed ID: 11706686
    [No Abstract] [Full Text] [Related]

  • 49. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun 15; 17(95):95-7. PubMed ID: 18623907
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated.
    Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP).
    MMWR Morb Mortal Wkly Rep; 2008 Apr 04; 57(13):343-4. PubMed ID: 18385642
    [Abstract] [Full Text] [Related]

  • 52. Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand.
    Lennon D, Jackson C, Wong S, Horsfall M, Stewart J, Reid S.
    Clin Infect Dis; 2009 Aug 15; 49(4):597-605. PubMed ID: 19622040
    [Abstract] [Full Text] [Related]

  • 53. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.
    Borrow R, Miller E.
    Expert Rev Vaccines; 2006 Dec 15; 5(6):851-7. PubMed ID: 17184222
    [Abstract] [Full Text] [Related]

  • 54. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.
    Kinlin LM, Jamieson F, Brown EM, Brown S, Rawte P, Dolman S, Drews SJ, Fisman DN.
    Vaccine; 2009 Mar 10; 27(11):1735-40. PubMed ID: 19186206
    [Abstract] [Full Text] [Related]

  • 55. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
    Chandramohan D, Hodgson A, Coleman P, Baiden R, Asante K, Awine E, Owusu-Agyei S, Boutriau D, Nelson CB, Greenwood B.
    Vaccine; 2007 Sep 03; 25 Suppl 1():A83-91. PubMed ID: 17521782
    [Abstract] [Full Text] [Related]

  • 56. Meningococcal C conjugate vaccination recommendations for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2007 Nov 03; 33(ACS-11):1-12. PubMed ID: 18064747
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.
    Keyserling HL, Pollard AJ, DeTora LM, Gilmet GP.
    Expert Rev Vaccines; 2006 Aug 03; 5(4):445-59. PubMed ID: 16989625
    [Abstract] [Full Text] [Related]

  • 59. Serogroup B meningococcal vaccines.
    Zimmer SM, Stephens DS.
    Curr Opin Investig Drugs; 2006 Aug 03; 7(8):733-9. PubMed ID: 16955685
    [Abstract] [Full Text] [Related]

  • 60. Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine.
    Ann Pharmacother; 2006 May 03; 40(5):1007. PubMed ID: 16670362
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.